1. Home
  2. GOVX vs TKLF Comparison

GOVX vs TKLF Comparison

Compare GOVX & TKLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GOVX
  • TKLF
  • Stock Information
  • Founded
  • GOVX 2001
  • TKLF 2006
  • Country
  • GOVX United States
  • TKLF Japan
  • Employees
  • GOVX N/A
  • TKLF N/A
  • Industry
  • GOVX Biotechnology: Pharmaceutical Preparations
  • TKLF Other Specialty Stores
  • Sector
  • GOVX Health Care
  • TKLF Consumer Discretionary
  • Exchange
  • GOVX Nasdaq
  • TKLF Nasdaq
  • Market Cap
  • GOVX 19.5M
  • TKLF 15.7M
  • IPO Year
  • GOVX N/A
  • TKLF 2022
  • Fundamental
  • Price
  • GOVX $1.67
  • TKLF $3.90
  • Analyst Decision
  • GOVX Strong Buy
  • TKLF
  • Analyst Count
  • GOVX 5
  • TKLF 0
  • Target Price
  • GOVX $14.20
  • TKLF N/A
  • AVG Volume (30 Days)
  • GOVX 569.4K
  • TKLF 19.4K
  • Earning Date
  • GOVX 03-03-2025
  • TKLF 12-18-2024
  • Dividend Yield
  • GOVX N/A
  • TKLF N/A
  • EPS Growth
  • GOVX N/A
  • TKLF N/A
  • EPS
  • GOVX N/A
  • TKLF 1.70
  • Revenue
  • GOVX $3,090,161.00
  • TKLF $219,520,631.00
  • Revenue This Year
  • GOVX N/A
  • TKLF N/A
  • Revenue Next Year
  • GOVX $150.51
  • TKLF N/A
  • P/E Ratio
  • GOVX N/A
  • TKLF $2.29
  • Revenue Growth
  • GOVX N/A
  • TKLF 32.02
  • 52 Week Low
  • GOVX $1.09
  • TKLF $2.00
  • 52 Week High
  • GOVX $11.18
  • TKLF $8.53
  • Technical
  • Relative Strength Index (RSI)
  • GOVX 37.32
  • TKLF 58.90
  • Support Level
  • GOVX $1.50
  • TKLF $3.52
  • Resistance Level
  • GOVX $1.79
  • TKLF $4.12
  • Average True Range (ATR)
  • GOVX 0.13
  • TKLF 0.20
  • MACD
  • GOVX 0.01
  • TKLF 0.02
  • Stochastic Oscillator
  • GOVX 29.82
  • TKLF 69.44

About GOVX GeoVax Labs Inc.

Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.

About TKLF Yoshitsu Co. Ltd

Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores; Online Stores and Services; and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from China followed by Japan and other overseas markets.

Share on Social Networks: